n,n-dideethylchloroquine has been researched along with piritrexim in 1 studies
| Studies (n,n-dideethylchloroquine) | Trials (n,n-dideethylchloroquine) | Recent Studies (post-2010) (n,n-dideethylchloroquine) | Studies (piritrexim) | Trials (piritrexim) | Recent Studies (post-2010) (piritrexim) |
|---|---|---|---|---|---|
| 23 | 0 | 1 | 124 | 21 | 6 |
| Protein | Taxonomy | n,n-dideethylchloroquine (IC50) | piritrexim (IC50) |
|---|---|---|---|
| Dihydrofolate reductase | Mycobacterium avium | 0.0006 | |
| Dihydrofolate reductase | Homo sapiens (human) | 0.0024 | |
| Dihydrofolate reductase | Lacticaseibacillus casei | 0.0015 | |
| Dihydrofolate reductase | Saccharomyces cerevisiae S288C | 0.031 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.0244 | |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 0.011 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.038 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.0257 | |
| Aromatic-L-amino-acid decarboxylase | Homo sapiens (human) | 0.0006 | |
| Dihydrofolate reductase | Candida albicans | 0.04 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.014 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0091 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0043 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0134 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0031 | |
| Dihydrofolate reductase | Pneumocystis jirovecii | 0.041 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for n,n-dideethylchloroquine and piritrexim
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |